Dec 17, 2024 · The FDA has sent CRLs to J&J and AstraZeneca, rejecting J&J's application for subcutaneous Rybrevant and AZ's bid for a full approval of Andexxa.

Jan 3, 2025 · Even as Novo and Lilly continue to climb, Roche looks poised to remain the top drugmaker by revenue in 2025, Evaluate analysts predict.

Jul 28, 2023 · Biogen has revealed a proposal to acquire Reata Pharmaceuticals for $7.3B. The Texas-based rare disease specialist brings newly approved Skyclarys.

Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.

Nov 27, 2024 · The treatment, which was once a Pfizer antidepressant, reduced bouts of cataplexy and other narcolepsy symptoms in Axsome's ENCORE study.

Nov 22, 2024 · Every year, Fierce’s pharma, biotech, and medtech teams come together to spotlight some of the fiercest women in life sciences—leaders who are transforming the industry with their innovation ...

Oct 29, 2024 · Novartis didn't use a priority review voucher for Pluvicto's new application upon a request from the FDA, CEO Vas Narasimhan explained.

This year, like so many others, has been a bit of a mixed bag for women, and especially for those seeking positions of power. For the second time in the last decade, a woman—the U.S.’ first ...

Jan 19, 2017 · The same way they do to vote for a favorite singer on “The Voice,” consumers can now text Pfizer for a discount on erectile dysfunction drug Viagra.

Nov 6, 2024 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...